Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Nucleix Wins €2.5M EU Grant for Lung Cancer Diagnostic

Nucleix Wins €2.5M EU Grant for Lung Cancer Diagnostic

Jul 30, 2018
|
staff reporter

NEW YORK (GenomeWeb) — Israeli molecular diagnostics firm Nucleix announced today that it has won a €2.5 million ($2.9 million) Horizon 2020 grant from the European Commission to continue development of its lung cancer screening test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Featured Webinar

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Molecular Diagnostics

  1. United Airlines Launches COVID-19 Testing Program for Travelers to Hawaii

  2. BioReference Settles False Claims, Kickback Allegations for $11.5M

  3. FDA Grants Emergency Use Authorizations for Quadrant Biosciences, KimForest Coronavirus Tests

  4. Vela Diagnostics Receives Second FDA Emergency Use Authorization for SARS-CoV-2 Molecular Test

  5. FDA Revises Emergency Use Authorization for Abbott Point-of-Care SARS-CoV-2 Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.